These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27431864)

  • 41. Penetration of fluorometholone into the cornea and aqueous humor.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1975 Jun; 93(6):425-7. PubMed ID: 1131082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ocular penetration of pilocarpine: the effect of pH on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1975 Feb; 7(2):293-6. PubMed ID: 235874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aqueous humor pilocarpine and timolol levels after instillation of the single drug or in combination.
    Ellis PP; Wu PY; Riegel M
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):520-2. PubMed ID: 2001926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological evaluation of a new timolol/pilocarpine formulation.
    Bucolo C; Spadaro A; Mangiafico S
    Ophthalmic Res; 1998; 30(2):101-6. PubMed ID: 9523288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination.
    Kalam MA; Alshamsan A; Aljuffali IA; Mishra AK; Sultana Y
    Drug Deliv; 2016; 23(3):896-907. PubMed ID: 24865289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles).
    Diepold R; Kreuter J; Himber J; Gurny R; Lee VH; Robinson JR; Saettone MF; Schnaudigel OE
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(2):188-93. PubMed ID: 2721988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Feb; 87(2):226-30. PubMed ID: 9519158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of topically applied pilocarpine on tear film pH.
    Longwell A; Birss S; Keller N; Moore D
    J Pharm Sci; 1976 Nov; 65(11):1654-7. PubMed ID: 11334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A corneal perfusion device for estimating ocular bioavailability in vitro.
    Richman JB; Tang-Liu DD
    J Pharm Sci; 1990 Feb; 79(2):153-7. PubMed ID: 2324964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of topical anesthesia on tear dynamics and ocular drug bioavailability in albino rabbits.
    Patton TF; Robinson JR
    J Pharm Sci; 1975 Feb; 64(2):267-71. PubMed ID: 1127583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs.
    Grass GM; Lee VH
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2251-9. PubMed ID: 8505206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
    Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular penetration of topically applied 1% daptomycin in a rabbit model.
    Sakarya R; Sakarya Y; Ozcimen M; Kesli R; Alpfidan I; Kara S
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):75-8. PubMed ID: 23020811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [An experimental study on corneal collagen shield vehicle for delivery of pilocarpine].
    Sun X; Chu R; Chen N
    Zhonghua Yan Ke Za Zhi; 1996 Mar; 32(2):143-6. PubMed ID: 9206235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of topically applied ophthalmic drugs.
    Shell JW
    Surv Ophthalmol; 1982; 26(4):207-18. PubMed ID: 7041308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.